Literature DB >> 7675087

Role of IRS-2 in insulin and cytokine signalling.

X J Sun1, L M Wang, Y Zhang, L Yenush, M G Myers, E Glasheen, W S Lane, J H Pierce, M F White.   

Abstract

The protein IRS-1 acts as an interface between signalling proteins with Src-homology-2 domains (SH2 proteins) and the receptors for insulin, IGF-1, growth hormone, several interleukins (IL-4, IL-9, IL-13) and other cytokines. It regulates gene expression and stimulates mitogenesis, and appears to mediate insulin/IGF-1-stimulated glucose transport. Thus, survival of the IRS-1-/- mouse with only mild resistance to insulin was surprising. This dilemma is provisionally resolved with our discovery of a second IRS-signalling protein. We purified and cloned a likely candidate called 4PS from myeloid progenitor cells and, because of its resemblance to IRS-1, we designate it IRS-2. Alignment of the sequences of IRS-2 and IRS-1 revealed a highly conserved amino terminus containing a pleckstrin-homology domain and a phosphotyrosine-binding domain, and a poorly conserved carboxy terminus containing several tyrosine phosphorylation motifs. IRS-2 is expressed in many cells, including tissues from IRS-1-/- mice, and may be essential for signalling by several receptor systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675087     DOI: 10.1038/377173a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  173 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1.

Authors:  S Dhe-Paganon; E A Ottinger; R T Nolte; M J Eck; S E Shoelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

3.  Multiple forms of p55PIK, a regulatory subunit of phosphoinositide 3-kinase, are generated by alternative initiation of translation.

Authors:  X Xia; G Serrero
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

Review 4.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats.

Authors:  V Páez-Espinosa; E M Rocha; L A Velloso; M J Saad
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 6.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

7.  Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats.

Authors:  H G Zecchin; R M N Bezerra; J B C Carvalheira; M A Carvalho-Filho; K Metze; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

8.  SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  The Gordon Wilson Lecture. Lessons about the control of glucose homeostasis and the pathogenesis of diabetes from knockout mice.

Authors:  C Ronald Kahn
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

10.  Regulation of insulin receptor substrate-2 tyrosine phosphorylation in animal models of insulin resistance.

Authors:  Fernanda Alvarez Rojas; Aparecida Emiko Hirata; Mario J A Saad
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.